Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BrainsWay Ltd. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BWAY
Nasdaq
3840
www.brainsway.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BrainsWay Ltd.
Undiscovered Middle East Gems To Explore In February 2026
- Feb 11th, 2026 1:33 am
BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™
- Jan 21st, 2026 5:30 am
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)
- Jan 12th, 2026 5:30 am
BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™
- Jan 7th, 2026 5:30 am
Middle East Hidden Gems Including Ayalon Insurance and 2 Promising Stocks
- Jan 5th, 2026 8:33 pm
BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens
- Dec 23rd, 2025 10:07 am
BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™
- Dec 22nd, 2025 5:30 am
Undiscovered Gems in Middle East to Explore This December 2025
- Dec 4th, 2025 8:33 pm
Are Options Traders Betting on a Big Move in BrainsWay Stock?
- Dec 2nd, 2025 8:12 am
BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025
- Nov 25th, 2025 5:30 am
BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder
- Nov 17th, 2025 5:30 am
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21
- Nov 13th, 2025 4:00 am
BrainsWay Ltd (BWAY) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
- Nov 11th, 2025 2:01 pm
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights
- Nov 11th, 2025 5:30 am
BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder
- Nov 4th, 2025 6:00 am
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
- Oct 28th, 2025 7:15 am
BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025
- Oct 28th, 2025 6:00 am
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
- Oct 27th, 2025 5:30 am
Are Medical Stocks Lagging Alkermes (ALKS) This Year?
- Oct 21st, 2025 7:40 am
Do Options Traders Know Something About Brainsway Stock We Don't?
- Sep 26th, 2025 11:29 am
Scroll